BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Ling Su Named New Drug Information Association Board President


8/7/2012 11:22:44 AM

HORSHAM, PA, USA—AUGUST 7, 2012— DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide, is pleased to announce the appointment of Dr Ling Su as President of the DIA Board of Directors.

Dr. Su is Senior Vice President and Head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai. Dr. Su brings more than 20 years of experience to DIA, specifically in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmacovigilance, pharmacoepidemiology, and outcomes research.

“Through my years of service in the industry, as an active DIA volunteer for 20 years, and now as DIA Board President, I plan on sharing my insight to help DIA and the industry overcome the challenges that we collectively face,” says Dr. Su. Dr. Su has served as chair of the DIA Provisional Advisory Council of China and received the DIA Outstanding Service Award in 2000.

Additional DIA Board members include:

• Minnie Baylor-Henry, JD, RPh, President- Elect

• Yves Juillet, MD, Immediate Past President

• John A Roberts, MBA, Treasurer

• Gesine Bejeuhr, PharmD

• Steve Caffe, MD

• Nancy A Dreyer, PhD, MPH, FISPE

• Sergio Guerrero, MD

• Truus Janse-de Hoog, PharmD, MSc

• Tatsuo Kurokawa, PhD

• Michele C Livesey, MBA

• Sandra A Milligan, JD, MD

• Frances J Richmond

• Jennifer L Riggins, PharmD

• Larisa Nagra Singh, MPharm

• Per Spindler, DVM, MBA, MSc

• Beat E Widler, PhD

• Ning Xu, MD,MBA

• Sandra L Kweder, MD, FDA Liaison

ABOUT DIA

DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. www.diahome.org. Follow DIA on FaceBook, Twitter, LinkedIn, and YouTube.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES